Spin-out company Mestag Therapeutics raises $11m seed cash

A spinout company co-founded by Official Fellow Mark Coles has launched with $11 million seed financing to develop new therapies against inflammatory disease and cancer.

The news was captured by Business Weekly, a Cambridge-based news outlet focused on business, innovation and technology.

Read our news story

Business Weekly (26/04/2021)